9.42 USD
↗ 0.17 (1.78%)LIVE (AS OF 12:06 PM EST)
Q32 Bio Inc. Common Stock
QTTBNASDAQ • USD
Market: OPEN
Shares of Q32 Bio Inc. Common Stock (QTTB) are trading at $9.42. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages. On the valuation side, QTTB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 6, 2026.
Open?$9.35
High?$9.60
Low?$9.03
Prev. Close?$9.25
Volume?158.3K
Avg. Volume?859.2K
VWAP?$9.40
Rel. Volume?0.18x
Bid / Ask
Bid?$8.07 × 100
Ask?$10.97 × 100
Spread?$2.90
Midpoint?$9.52
Valuation & Ratios
Market Cap?276.8M
Shares Out?29.9M
Float?17.3M
Float %?58.2%
P/E Ratio?8.58
P/B Ratio?0.96
EPS?$1.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Address
830 WINTER STREET
WALTHAM, MA 02451
Phone: 781-999-0232
WALTHAM, MA 02451
Phone: 781-999-0232
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?33
Piotroski F-Score?0/9Weak
Altman Z-Score?17.88Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?32.63%Squeeze Risk
Short Interest?5.7M
Days to Cover?5.3
Free Float17.3M
Avg Daily Volume1.1M
Settlement Date2026-10-15
Financial Health
Current Ratio?56.34Strong
Quick Ratio?56.34Strong
Cash Ratio?56.05Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?8.6CHEAP▾
Peers100
S&P97
P/B?0.96CHEAP▾
Peers100
S&P97
P/S?5.15FAIR▾
Peers100
S&P28
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?-0.24CHEAP▾
S&P97
Returns & Efficiency
ROE?11.2%FAIR▾
Peers50
S&P40
ROA?10.9%STRONG▾
Peers50
S&P77
Cash Flow & Enterprise
FCF?$-20068000
Enterprise Value?$-12791092
Fundamentals ratios updated end of day